Sunday 18 October 2026 Export FATE’s income statement to Excel — free account

Fate Therapeutics, Inc.

Fate Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 million, down 51.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.18%, EPS grew 13.8% and free cash flow grew 8.96%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

1.79 0.14 −7.25%

Follow FATE

Alert me

Market cap: $230.7M
P/E: 0.0×
Fwd P/E: −1.8×
Dividend yield: —
F-score: 3/9
Altman Z: −6.97
Beneish M: −4.02
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		21.01	17.52	22.81	50.08
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(6.15)	(4.99)	(4.67)	(13.87)
P/B ratio Full definition →		0.64	0.56	0.80	2.12
Price to Tangible BV Full definition →		0.64	0.56	0.80	2.12
EV/Sales Full definition →		(5.90)	(9.61)	(1.17)	30.00
EV/EBITDA Full definition →		0.26	0.46	0.06	0.00
EV/Operating CF Full definition →		0.38	0.60	0.07	(1.91)
EV/FCF Full definition →		0.37	0.57	0.07	(1.85)
Quick Ratio Full definition →		7.69	5.67	5.72	4.74
Current Ratio Full definition →		7.87	5.79	5.85	4.85
Net Debt/EBITDA Full definition →		6.67	6.26	5.67	5.28
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.02	0.02	0.02	0.02
Operating CF/Net income Full definition →		0.76	0.72	0.99	0.78
Capex/Depreciation Full definition →		(0.91)	(0.44)	(0.11)	(0.04)
Research and Development Expense of Revenue Full definition →		1,484.09%	1,857.20%	1,901.69%	1,171.33%
Selling, General and Administrative Expense of Revenue Full definition →		611.03%	779.04%	738.72%	424.06%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		279.21%	403.80%	302.46%	168.97%
Graham Net Nets Full definition →		0.74	0.83	0.52	0.16
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(104.76%)	(117.35%)	(90.83%)	(38.89%)
Free Cash Flow Yield Full definition →		(76.90%)	(95.93%)	(74.79%)	(32.43%)
Revenue per Share Full definition →		0.01	0.01	0.01	0.02
Operating CF per Share Full definition →		(0.20)	(0.20)	(0.26)	(0.19)
Capex per Share Full definition →		(0.02)	(0.01)	0.00	0.00
Free Cash Flow per Share Full definition →		(0.22)	(0.20)	(0.26)	(0.20)
Cash per Share Full definition →		1.81	1.71	1.46	1.28
Shareholders Equity per Share Full definition →		1.97	1.74	1.50	1.27
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		1.97	1.74	1.50	1.27
Free Cash Flow Full definition →		(26.57)	(24.27)	(31.06)	(23.51)
Working Capital Full definition →		193.14	172.63	148.84	125.36
Capital Expenditures Full definition →		(2.20)	(0.95)	(0.24)	(0.08)
Net Current Asset Value Full definition →		111.65	96.95	74.32	51.29
EV/EBIT Full definition →		0.24	0.43	0.05	0.00
Capex to Sales Full definition →		1.26	0.70	0.18	0.04
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		2.40	2.23	1.56	1.05
Average Payables Full definition →		4.93	6.01	3.73	3.65
Average Assets Full definition →		419.32	379.82	341.79	315.87
Average Common Equity Full definition →		298.19	262.95	234.06	207.40

Show all line items

Columns are period end dates

Stockrow Weekly